Brazilian President Bolsonaro.
The first article is used to explain the help provided by the Chinese government to Brazil. He wrote: “The Chinese Embassy informed us in the morning that 5400L of export materials for the new crown vaccine (referring to the active ingredients used to produce the new crown vaccine) will arrive in the next few days. Therefore, AstraZeneca’s vaccine supply is also in progress. accelerate.”
The second tweet thanked the Chinese government: “I thank the Chinese government for its compassion and my ministers for their efforts.”
Bolsonaro thanked China for promptly approving the export of vaccine active ingredients, which helped the Butantan Biomedical Center in Sao Paulo produce approximately 8.5 million doses of Kexing’s inactivated vaccine. At the same time, China has quickly approved the export of the active ingredients of the AstraZeneca adenovirus vaccine being manufactured in Brazil.
The shortage of vaccines has been plagued this South American country recently. Brazilian scientists complained that the country encountered various problems as soon as the vaccination campaign was launched, and the government resigned the blame. Last weekend, thousands of people in several Brazilian cities staged protests and demanded that the president step down.
According to data from Johns Hopkins University in the United States, as of 9 am yesterday (January 26), the cumulative number of confirmed cases in Brazil has exceeded 8.87 million, ranking third in the world. Brazil has accumulated more than 217,000 deaths, second only to the United States in the world.
Because Brazil, a country with a population of 210 million, has few people vaccinated, and coupled with the second wave of the epidemic, Brazil now finds itself almost entirely dependent on the Chinese new crown vaccine.
The Butantan Biomedical Center in Sao Paulo has signed a contract for 46 million doses of vaccine with Kexing Biotech. The first batch of 6 million doses is ready and has been distributed throughout Brazil. The rest must be produced by Butantan itself.
–
The Fiocruz Institute, funded by the Brazilian federal government, said on Monday that it expects China to deliver the active ingredients needed for the new crown vaccine to the local area around February 8. According to reports, the Fior Cruz Institute has reached an agreement with AstraZeneca Pharmaceuticals in the United Kingdom to produce up to 100 million doses of vaccine, but there is no required active ingredient.
Regarding China-Pakistan vaccine cooperation, at the regular press conference of the Ministry of Foreign Affairs on January 20, Foreign Ministry spokesperson Hua Chunying emphasized that China always puts the safety and effectiveness of vaccines first. Chinese vaccine research and development companies have always promoted vaccine research and development in strict accordance with scientific laws and regulatory requirements, and strictly abide by international norms and relevant laws and regulations to carry out international cooperation. Chinese and Pakistani companies and institutions jointly launched the Phase 3 clinical trial of COVID-19 in Pakistan. It is believed that the cooperation will play a positive role in the fight against the epidemic for the people of China and Pakistan. China is willing to continue cooperation in this area with Brazil. “
Brazilian President Bolsonaro is very pro-American, but he can’t get the American epidemic. The American pharmaceutical companies Pfizer and Moderna, as well as the British pharmaceutical company AstraZeneca, also have no active ingredients from the disease to Brazil. In the end, only China is willing to help.
– .
Related
